• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY:MRK)

    83.93 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Sep 30, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 24,910
    Open 83.93
    Bid (Size) 84.14 (4)
    Ask (Size) 84.30 (1)
    Prev. Close 83.93
    Today's Range 83.93 - 83.93
    52wk Range 73.31 - 114.79
    Shares Outstanding 2,531,374,696
    Dividend Yield 3.86%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30
    From Merck & Co., Inc.
    Via Business Wire
    Global Markets Defy Headwinds: Resilient Sentiment Prevails Despite Shutdown Fears
    As the third quarter of 2025 drew to a close on September 30, global financial markets demonstrated a remarkable display of resilience, largely shrugging off significant geopolitical uncertainties and... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Government

    Performance

    YTD
    -15.4%
    -15.4%
    1 Month
    -1.8%
    -1.8%
    3 Month
    +2.6%
    +2.6%
    6 Month
    -3.7%
    -3.7%
    1 Year
    -26.1%
    -26.1%

    More News

    Read More
    Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
    Via MarketMinute
    Topics Economy Government World Trade
    What's going on in today's session: S&P500 movers
    Via Chartmill
    Merck (MRK) Shares Skyrocket, What You Need To Know
    Via StockStory
    Topics Artificial Intelligence
    IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine
    Via Stocktwits
    Pharmaceutical Tariffs ‘A Light At The End Of The Trump Tunnel’ For Big Pharma, Says Jefferies
    Via Stocktwits
    Topics Government
    Tech Revolutionizes Cattle Feeding: A Sustainable Future for Livestock Markets
    Via MarketMinute
    Topics Artificial Intelligence Climate Change Emissions
    Discover which S&P500 stocks are making waves on Tuesday.
    Via Chartmill
    Merck's Winrevair Cuts Clinical Worsening Risk By 76% Among Hypertension Patients
    Via Benzinga
    Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened
    Via Stocktwits
    WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial
    From Merck Sharp & Dohme
    Via Business Wire
    Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes
    Via MarketMinute
    U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears
    Via MarketMinute
    Topics Bonds Economy Government
    Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program
    Via Stocktwits
    Topics Government
    Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers
    Via MarketMinute
    Topics Economy Intellectual Property
    Healthcare Sector Reels: A Deep Dive into Thursday's -1.67% Plunge
    Via MarketMinute
    Topics Economy
    Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
    Via Benzinga
    Topics Government World Trade
    Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now
    Via The Motley Fool
    Topics Artificial Intelligence
    Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
    Via Benzinga
    Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America
    Via Stocktwits
    Topics Government
    Moderna Stands By UK As Pharma Giants Criticize Pricing, UK Secures First Onshore mRNA Vaccine Production Centre
    Via Benzinga
    Peering Into Merck & Co's Recent Short Interest
    Via Benzinga
    Merck & Co. Inc. (NYSE:MRK): A Prime Candidate for a Dependable Dividend Portfolio
    Via Chartmill

    Frequently Asked Questions

    Is Merck & Co publicly traded?
    Yes, Merck & Co is publicly traded.
    What exchange does Merck & Co trade on?
    Merck & Co trades on the New York Stock Exchange
    What is the ticker symbol for Merck & Co?
    The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
    What is the current price of Merck & Co?
    The current price of Merck & Co is 83.93
    When was Merck & Co last traded?
    The last trade of Merck & Co was at 09/30/25 07:00 PM ET
    What is the market capitalization of Merck & Co?
    The market capitalization of Merck & Co is 212.46B
    How many shares of Merck & Co are outstanding?
    Merck & Co has 212B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.